Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106479

On the mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA)

Anthony Sebastian, Elisabeth McSherry, and R. Curtis Morris Jr.

Department of Medicine, University of California, San Francisco, California 94122

Department of Pediatrics, University of California, San Francisco, California 94122

Find articles by Sebastian, A. in: PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, California 94122

Department of Pediatrics, University of California, San Francisco, California 94122

Find articles by McSherry, E. in: PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, California 94122

Department of Pediatrics, University of California, San Francisco, California 94122

Find articles by Morris, R. in: PubMed | Google Scholar

Published January 1, 1971 - More info

Published in Volume 50, Issue 1 on January 1, 1971
J Clin Invest. 1971;50(1):231–243. https://doi.org/10.1172/JCI106479.
© 1971 The American Society for Clinical Investigation
Published January 1, 1971 - Version history
View PDF
Abstract

The mechanism of renal potassium wasting in renal tubular acidosis associated with the Fanconi syndrome (type 2 RTA) was investigated in 10 patients, each of whom had impaired proximal renal tubular reabsorption of bicarbonate as judged from a greater than 15-20% reduction of renal tubular bicarbonate reabsorption (THCO3-) at normal plasma bicarbonate concentrations. When the plasma bicarbonate concentration ([HCO3-]p) was experimentally increased to normal levels in three patients with a fractional potassium excretion (CK/Cin) of less than 1.0 during acidosis, CK/Cin and urinary potassium excretion (UKV/Cin) increased strikingly and concurrently with a striking increase in urinary sodium (UNaV/Cin) and bicarbonate (UHCO3-V/Cin) excretion. When [HCO3-]p was increased to normal levels in two patients with a CK/Cin of greater than 1.0 during acidosis and in whom UNaV/Cin and UHCO3-V/Cin were already markedly increased, CK/Cin did not increase further. When [HCO3-]p was decreased to subnormal levels in a patient given ammonium chloride, UKV/Cin, CK/Cin, and UHCO3-V/Cin decreased concurrently. In the six patients in whom [HCO3-]p was maintained at normal levels (oral alkali therapy) for 2 months or longer, CK/Cin was directly related to the urinary excretion rates of sodium and bicarbonate, hence was directly related to the magnitude of reduction of THCO3- at normal [HCO3-]p; CK/Cin was greater than 0.55 in all six patients and greater than 1.0 in four.

In eight patients with classic RTA (type 1 RTA), proximal renal tubular reabsorption of bicarbonate was largely intact as judged from a trivial reduction of THCO3- at normal [HCO3-]p. When [HCO3-]p was either increased from subnormal to normal levels, or decreased from normal to subnormal levels, UHCO3-V/Cin remained essentially constant, and UKV/Cin did not change significantly. When correction of acidosis was sustained, UHCO3-V/Cin remained a trivial fraction of that filtered, and CK/Cin was consistently less than 0.55.

These results provide evidence that renal potassium wasting in type 2 RTA is physiologically separable from that in type 1 RTA and in part the result of a reduction in the rate at which the proximal tubule reabsorbs bicarbonate and the distal delivery of supernormal amounts of sodium bicarbonate. With an increased stimulus to distal sodium reabsorption, indicated by the finding of hyperaldosteronism, delivery to the distal nephron of supernormal amounts of sodium with the relatively impermeant bicarbonate anion would be expected to increase intraluminal negativity in the distal nephron, and as a consequence, increase potassium secretion and promote renal potassium wasting.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 231
page 231
icon of scanned page 232
page 232
icon of scanned page 233
page 233
icon of scanned page 234
page 234
icon of scanned page 235
page 235
icon of scanned page 236
page 236
icon of scanned page 237
page 237
icon of scanned page 238
page 238
icon of scanned page 239
page 239
icon of scanned page 240
page 240
icon of scanned page 241
page 241
icon of scanned page 242
page 242
icon of scanned page 243
page 243
Version history
  • Version 1 (January 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts